Curexsys is active in the anti-aging field and develops exosomes as innovative therapeutics to cure age-related diseases.
Curexsys is active in the anti-aging field and combats age-related defects with exosomes derived from induced mesenchymal stem cells (iMSCs). Exosomes constitute a new therapeutic principle clearly distinct from classical small or large molecule compounds or cell therapy. They are small vesicles that are naturally released from a cell. They contain proteins, nucleic acids and metabolites, which carry information from secreting to receiving cells. Exosomes have immunomodulatory and anti-inflammatory effects.
Due to increasingly aging societies, anti-aging therapies are of great interest to the pharma industry, health care providers and aging populations, and the Curexsys exosome platform will serve the arising demand of pure and functional exosomes in pharma industry. With the leading technology for highly selective and traceless purification of extracellular vesicles with low-affinity Fabs, Curexsys uses a unique technology to generate products for clinical applications, matching medical needs with increasing patient numbers in multiple disease areas.
Find out more